Searchable abstracts of presentations at key conferences in endocrinology

ea0016p172 | Diabetes and cardiovascular diseases | ECE2008

Changes in the sympathetic and sensory innervation of the tail artery, adrenal gland and male reproductive organs of glucose-intolerant Goto-Kakazaki (GK) rats

Morrison John , Dhanasekaran Subramanian , Howarth Christopher

Twelve-month-old GK rats that showed glucose intolerance were compared with age matched Wistar rats. The concentrations of noradrenaline (NA), adrenaline (ADR) dopamine (DOP), Neuropeptide Y (NPY), and calcitonin gene-related peptide (CGRP) were measured in tissue samples. The objective was to assess whether glucose intolerance was associated with changes in the noradrenergic and peptidergic nerves innervating the tail artery (TA), seminal vesicle (SV) and corpus cavernosum (C...

ea0034oc6.1 | Clinical | SFEBES2014

Adverse outcome in glucocorticoid induced adrenal suppression; an analysis of short synacthen tests in 2782 patients

Chapman Matthew , Argese Nicola , Mani Dhanasekaran , Dabhi Vijay , Boot Christopher , Crowley Rachel , Stewart Paul , Tomlinson Jeremy

2–3% of the UK population are prescribed glucocorticoid (GC) therapy and their adverse effects contribute to a significant health burden. Suppression of endogenous GC secretion is a recognized complication of therapy, but the magnitude of the problem, together with its clinical consequences have not been determined. We conducted a retrospective study across all specialties in a large secondary–tertiary care center identifying 2782 patients who underwent 3666 250 &#95...

ea0011p297 | Diabetes, metabolism and cardiovascular | ECE2006

Decreased cardiac and arterial noradrenaline and dopamine concentrations occur concomitantly with the development of type II diabetes in rats treated neonatally with monosodium glutamate (MSG): a possible basis for autonomic neuropathy?

Morrison JFB , Shaffiullah M , Dhanasekaran S , Sheen R , Mensah-Brown EK

Neonatal rats were treated with MSG (4G/Kg daily for 7 days). Glucose tolerance tests (GTT) were performed at 32, 65 and 70 weeks. After one year there was evidence of Type II diabetes, and the blood glucose levels were significantly greater than the controls for several points in the GTT; islet beta-cells were unchanged, cataracts were often present and there was central obesity.The amines in the heart, proximal tail artery, kidneys and adrenals were ex...